061447Y
Bypass Hepatic Vein to Lower Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 6 Lower Veins |
| Operation | 1 Bypass |
| Body Part | 4 Hepatic Vein |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Y Lower Vein |
Operation Definition
Altering the route of passage of the contents of a tubular body part
Procedure Overview
Bypass procedures on the lower veins create a new pathway for blood to flow around a blocked or damaged section of a vein in the leg, pelvis, or abdomen. Surgeons typically use a segment of the patient's own vein, a synthetic graft, or a section of another vessel to route blood past the obstruction, restoring normal circulation and relieving symptoms like swelling, pain, or skin changes caused by poor venous return.
This is most often performed for severe venous insufficiency, chronic deep vein thrombosis that has scarred a vein shut, or May-Thurne syndrome where the iliac vein is compressed. A well-known example is the Palma procedure, which reroutes blood from a blocked iliac vein across the pelvis into the healthy vein on the opposite side using a segment of the patient's own saphenous vein.
Anatomy & Axis Detail
Hepatic Vein
The hepatic veins carry blood from the liver parenchyma into the inferior vena cava just below the diaphragm, and their patency is essential for normal hepatic venous outflow. Obstruction of one or more hepatic veins, as occurs in Budd-Chiari syndrome from thrombosis, webs, or tumor compression, causes hepatic congestion, ascites, and progressive liver dysfunction. Bypass in this location reroutes blood around the blocked vein, frequently using a mesocaval or portosystemic conduit, or a direct hepatic-vein-to-cava graft, to relieve sinusoidal congestion and preserve hepatic function. Because the hepatic veins are short and intimately associated with liver segments, the procedure demands careful attention to which hepatic vein is involved and where the bypass conduit terminates, both of which should be explicitly documented.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Qualifier: Lower Vein
This qualifier marks a vein of the lower extremity, pelvis, or abdomen as the procedural target when no more specific named vessel is documented. It functions as the counterpart to Upper Vein, and the choice between the two depends solely on which general body region the treated vein belongs to.
Coding & Documentation
Coders need operative documentation naming both the vein being bypassed and where the new pathway terminates, since ICD-10-PCS bypass codes require identifying the qualifier vessel or body part that receives the rerouted flow. The type of conduit used, whether autologous vein, synthetic graft, or another patient tissue, is also captured in the device or qualifier character and must be pulled directly from the operative report.
A common mistake is defaulting to a same-vessel body part when the graft actually connects to a different named vein, which changes the qualifier value and can misrepresent the extent of the procedure. Coders also sometimes overlook that harvesting the graft vessel itself may warrant a separate Excision code if it's a distinct procedure rather than an inherent part of bypass graft preparation.